Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
Clinical trial NCT04562766 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04562766
- Sponsor
- Principia Biopharma, a Sanofi Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2025-01-15
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.